Aarti Pharmalabs Ltd. benchmarking: Perfomance to industry peers

Financial

	Aarti Pharmalabs	Shilpa Medicare	Supriya Lifescience
Operational Metrics
Financials
5 yr Average ROE	9.05 %	3.31 %	23.4 %
5yr average Equity Multiplier	1.39	1.62	1.25
5yr Average Asset Turnover Ratio	0.58	0.37	0.68
5yr Avg Net Profit Margin	8.95 %	5.49 %	25.52 %
Price to Book	3.85	2.95	6.43
P/E	28.73	63.05	35.98
5yr Avg Cash Conversion Cycle	94.46 Days	92.76 Days	-10.96 Days
Inventory Days	94.9 Days	108.8 Days	56.1 Days
Days Receivable	94.46 Days	118.16 Days	57.43 Days
Days Payable	76.47 Days	123.42 Days	113.66 Days
5yr Average Interest Coverage Ratio	12.05	3.59	60.74
5yr Avg ROCE	12.13 %	5.94 %	30.51 %
5yr Avg Operating Profit Margin	15.5 %	17.75 %	36.15 %
5 yr average Debt to Equity	0.16	0.43	0.06
5yr CAGR Net Profit	n/a	-11.93 %	8.75 %
5yr Average Return on Assets	6.11 %	2.0 %	17.81 %
Shareholdings
Promoter Holding	42.88 %	44.23 %	68.3 %
Share Pledged by Promoters	0.01 %	7.92 %	0.0
Change in Promoter Holding (3 Yrs)	-3.1 %	-5.78 %	0.06 %
Change in Mutual Fund Holding (3 Yrs)	-4.32 %	3.25 %	-1.7 %

	Aarti Pharmalabs	Shilpa Medicare	Supriya Lifescience
Product Wise Break-Up	Product Wise Break-Up Xanthine 49.6 API 40.8 CDMO 9.6 Power sales 0 Pharmaceutical product and services 0 Pharmaceuticals 0	Product Wise Break-Up Xanthine 0 CDMO 0 API 0 Pharmaceuticals 0 Power sales 0 Pharmaceutical 100.0	Product Wise Break-Up Xanthine 0 CDMO 0 API 0 Pharmaceuticals 100.0 Power sales 0 Pharmaceutical product and services 0
Location Wise Break-Up	Location Wise Break-Up India 49.0 Rest of the World 0 Europe 0 USA 0 North America 0 LAC 0 Others 51.0	Location Wise Break-Up Rest of the World 36.73 Europe 31.63 LAC 0 North America 0 USA 18.37 India 9.18 Others 4.09	Location Wise Break-Up Rest of the World 0 Europe 41.0 Latin America 17.0 North America 4.0 USA 0 India 0 Others 38.0
Customer Segment	Customer Segment Home and Personal care 100.0	-	-